PREDICEN at the Onco Startup Summit 2026: A Day of Collaboration and Innovation in Oncology

The Onco Startup Summit, held on June 18, 2026, in Paris, brought together key players in oncology innovation. Our company, PREDICEN, had the opportunity to present its latest developments during this event, organized as part of the 9th French Interdisciplinary Oncology Days (IFODS). The summit provided a unique opportunity to engage with startups, investors, experts, and support organizations around the major challenges shaping the future of medicine.

An Event at the Heart of Oncology Innovation

Each year, the Onco Startup Summit brings together stakeholders committed to the fight against cancer. This year's edition highlighted several critical challenges facing startups in the field, including preparing for fundraising, addressing the challenges of clinical trials, gaining access to specialized investors and making strategic decisions to transform innovation into therapeutic solutions accessible to patients.

These topics are essential for companies like PREDICEN, which develops solutions aimed at improving the personalization of cancer treatments. Participating in events like this allows us to challenge our ideas and gain a deeper understanding of market expectations. The feedback we received during the Onco Startup Summit helps us refine our approach to better meet clinical needs and patient expectations.

Following this inspiring day, we leave with valuable connections and renewed motivation. The Onco Startup Summit once again demonstrated the importance of bringing together the oncology innovation ecosystem to develop practical, impactful solutions in the fight against cancer.

We would like to sincerely thank the event organizers: Angels Santé, Gustave Roussy Transfert, MATWIN, OncoSTART, Paris Saclay Cancer Cluster, and the SATT Network.